BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37387257)

  • 1. Gastrointestinal barrier integrity and mucosal inflammation as risk factors of blood stream infections in children treated for acute lymphoblastic leukaemia.
    De Pietri S; Weischendorff S; Rathe M; Frandsen TL; Hasle H; Nersting J; Nielsen CH; Moser C; Müller K
    Int J Cancer; 2023 Nov; 153(9):1635-1642. PubMed ID: 37387257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of intestinal mucositis to predict blood stream infections at the onset of fever during treatment for childhood acute leukemia.
    Weischendorff S; Rathe M; Petersen MJ; Weimann A; Enevold C; Nielsen CH; Als-Nielsen B; Nygaard U; Moser C; Müller K
    Leukemia; 2024 Jan; 38(1):14-20. PubMed ID: 37919603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: The impact of the gut microbiota.
    De Pietri S; Ingham AC; Frandsen TL; Rathe M; Krych L; Castro-Mejía JL; Nielsen DS; Nersting J; Wehner PS; Schmiegelow K; Hasle H; Pamp SJ; Müller K
    Int J Cancer; 2020 Oct; 147(7):1953-1962. PubMed ID: 32115690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citrulline as a biomarker of bacteraemia during induction treatment for childhood acute lymphoblastic leukaemia.
    De Pietri S; Frandsen TL; Christensen M; Grell K; Rathe M; Müller K
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28793. PubMed ID: 33155402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of neutrophil chemotaxis for identification of blood stream infections in children with acute lymphoblastic leukemia undergoing induction treatment.
    Weischendorff S; De Pietri S; Rathe M; Frandsen TL; Hasle H; Nielsen CH; Moser C; Müller K
    Eur J Haematol; 2023 Jun; 110(6):762-771. PubMed ID: 36950865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grading bloodstream infection risk using citrulline as a biomarker of intestinal mucositis in patients receiving intensive therapy.
    de Mooij CEM; van der Velden WJFM; de Haan AFJ; Fazel S; van Groningen LFJ; Blijlevens NMA
    Bone Marrow Transplant; 2022 Sep; 57(9):1373-1381. PubMed ID: 35661156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients.
    van Vliet MJ; Tissing WJ; Rings EH; Koetse HA; Stellaard F; Kamps WA; de Bont ES
    Pediatr Blood Cancer; 2009 Dec; 53(7):1188-94. PubMed ID: 19688831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapeutic treatment reduces circulating levels of surfactant protein-D in children with acute lymphoblastic leukemia.
    Rathe M; Sorensen GL; Wehner PS; Holmskov U; Sangild PT; Schmiegelow K; Müller K; Husby S
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27667327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bloodstream infection in paediatric cancer centres--leukaemia and relapsed malignancies are independent risk factors.
    Ammann RA; Laws HJ; Schrey D; Ehlert K; Moser O; Dilloo D; Bode U; Wawer A; Schrauder A; Cario G; Laengler A; Graf N; Furtwängler R; Simon A
    Eur J Pediatr; 2015 May; 174(5):675-86. PubMed ID: 25804192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
    Vora A; Goulden N; Mitchell C; Hancock J; Hough R; Rowntree C; Moorman AV; Wade R
    Lancet Oncol; 2014 Jul; 15(8):809-18. PubMed ID: 24924991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State of the art: the role of citrulline as biomarker in patients with chemotherapy- or graft-versus-host-disease-induced mucositis.
    Dekker IM; Bruggink H; van der Meij BS; Wierdsma NJ
    Curr Opin Clin Nutr Metab Care; 2021 Sep; 24(5):416-427. PubMed ID: 34155153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum citrulline as a biomarker of gastrointestinal function during hematopoietic cell transplantation in children.
    Gosselin KB; Feldman HA; Sonis AL; Bechard LJ; Kellogg MD; Gura K; Venick R; Gordon CM; Guinan EC; Duggan C
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):709-14. PubMed ID: 24614125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma citrulline level as a biomarker for cancer therapy-induced small bowel mucosal damage.
    Barzał JA; Szczylik C; Rzepecki P; Jaworska M; Anuszewska E
    Acta Biochim Pol; 2014; 61(4):615-31. PubMed ID: 25473654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of MTHFR and ABCB1 polymorphisms with MTX-induced mucositis in Chinese paediatric patients with acute lymphoblastic leukaemia, lymphoma or osteosarcoma-A retrospective cohort study.
    Gong Y; Luo L; Wang L; Chen J; Chen F; Ma Y; Xu Z; Sun Y; Luo L; Shi C; Li X
    J Clin Pharm Ther; 2021 Dec; 46(6):1557-1563. PubMed ID: 34346513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-therapy fasting slows epithelial turnover and modulates the microbiota but fails to mitigate methotrexate-induced gastrointestinal mucositis.
    Wardill HR; da Silva Ferreira AR; Lichtenberg Cloo S; Havinga R; Harmsen HJM; Vermeij WP; Tissing WJE
    Gut Microbes; 2020 Nov; 12(1):1-9. PubMed ID: 32844722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of minimal enteral feeding on recovery in a methotrexate-induced gastrointestinal mucositis rat model.
    Kuiken NS; Rings EH; Havinga R; Groen AK; Tissing WJ
    Support Care Cancer; 2016 Mar; 24(3):1357-64. PubMed ID: 26335404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients.
    Vanstraelen K; Prattes J; Maertens J; Lagrou K; Schoemans H; Peersman N; Vermeersch P; Theunissen K; Mols R; Augustijns P; Annaert P; Hoenigl M; Spriet I
    Eur J Clin Pharmacol; 2016 Aug; 72(8):953-63. PubMed ID: 27066958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Mucositis in Pediatric Acute Lymphoblastic Leukemia Patients: Evaluation of Microbiological and Hematological Factors.
    Mendonça RM; Araújo Md; Levy CE; Morari J; Silva RA; Yunes JA; Brandalise SR
    Pediatr Hematol Oncol; 2015; 32(5):322-30. PubMed ID: 26086683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decrease in vitamin D levels is associated with methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
    Oosterom N; Dirks NF; Heil SG; de Jonge R; Tissing WJE; Pieters R; van den Heuvel-Eibrink MM; Heijboer AC; Pluijm SMF
    Support Care Cancer; 2019 Jan; 27(1):183-190. PubMed ID: 29922939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.